Skip to main content
OA

OtonoCo AI

OtonoCo develops AI-driven applications, OtonoSTEM and OtonoSINA, that utilize Generative and Autonomous AI to enhance educational experiences and improve patient care. OtonoSTEM transforms STEM and arts education into interactive learning adventures, while OtonoSINA provides personalized medical insights and second opinions, addressing gaps in communication and understanding between patients and healthcare providers.

Singapore, SingaporeFounded 20233100+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Students in STEM and arts education often struggle with complex subjects due to a lack of engaging and interactive learning resources. Patients may experience communication barriers with healthcare providers, leading to misunderstandings and impacting the quality of care.

Solution

OtonoCo develops AI-powered educational and patient-care applications. OtonoSTEM is an autonomous teaching and learning app that transforms STEM and arts education into interactive experiences with a virtual teaching assistant, curriculum generator, and engineering design activities. OtonoSINA bridges communication gaps between doctors and patients by translating clinical findings into personalized knowledge and providing AI-driven second opinions, improving patient understanding and care.

Target Audience

OtonoSTEM targets students, teachers, educators, teaching assistants, and professors in STEM and arts fields. OtonoSINA is designed for patients and healthcare providers seeking to improve communication and understanding in patient care.

Features

  • OtonoSTEM includes OtonoTA, a virtual teaching assistant that creates fun activities for STEM and arts subjects.
  • OtonoPROF autonomously generates new curriculum, content, problem sets, and quizzes for educators.
  • OtonoPE turns teaching and learning experiences into engineering design projects.
  • OtonoSINA uses OpenAI GPT to translate clinical findings, diagnoses, and treatments into personalized knowledge for patients.
  • OtonoSINA provides AI-driven second opinions based on clinical findings, cultural, and language needs.
This profile is AI-generated and may contain inaccuracies.